Latest papers

Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research.

BDNF levels are not related with levodopa-induced dyskinesias in MPTP monkeys.

Treatment of a tardive dyskinesia patient with temporomandibular disorder: a case report.

Tardive oculogyric crisis associated with amisulpride monotherapy.

Levodopa in the treatment of Parkinson's disease: an old drug still going strong.

Extrapyramidal syndrome related to lithium-carbamazepine combination therapy at therapeutic serum levels.

The management of a completely edentulous patient with tardive dyskinesia.

Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review.

[Dopamine agonist therapy in early Parkinson's disease. A survey of a Cochrane review].

Metoclopramide: tardive dyskinesia. Beware long-term use.

Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia.

Genetic Inactivation of Dopamine D1 but Not D2 Receptors Inhibits L-DOPA–Induced Dyskinesia and Histone Activation

[Management of Parkinson's disease in 2009]

Ziprasidone in Black patients with schizophrenia: analysis of four short-term, double-blind studies.

[Local botulinum neurotoxin A therapy in tardive lingual dyskinesia]

Drug-induced dyskinesias.

Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review.

[Neuroleptic adverse effects with emphasis on weight gain].

Effect of Hibiscus rosa sinensis on reserpine-induced neurobehavioral and biochemical alterations in rats.

Neuroleptic induced tardive dyskinesia in a patient on treatment for schizophrenia: case report.